{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T18:36:11Z","timestamp":1782671771268,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,9,15]],"date-time":"2010-09-15T00:00:00Z","timestamp":1284508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s11926-010-0130-1","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T10:49:23Z","timestamp":1284461363000},"page":"414-419","source":"Crossref","is-referenced-by-count":62,"title":["Rheumatoid Vasculitis: Vanishing Menace or Target for New Treatments?"],"prefix":"10.1007","volume":"12","author":[{"given":"Christie M.","family":"Bartels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,15]]},"reference":[{"key":"130_CR1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00005792-198107000-00004","volume":"60","author":"DG Scott","year":"1981","unstructured":"Scott DG, Bacon PA, Tribe CR: Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine 1981, 60:288\u2013297.","journal-title":"Medicine"},{"key":"130_CR2","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1002\/art.24775","volume":"60","author":"C Bartels","year":"2009","unstructured":"\u2022\u2022 Bartels C, Bell C, Rosenthal A, et al.: Decline in rheumatoid vasculitis prevalence among US veterans: a retrospective cross-sectional study. Arthritis Rheum 2009, 60:2553\u20132557. This cross-sectional study examined more than 20\u00a0years of national data representing more than 37,000 RA patients annually to demonstrate the declining prevalence of rheumatoid vasculitis in the inpatient and outpatient settings, with breakpoints around 2000 suggesting a possible link to new biologic treatments.","journal-title":"Arthritis Rheum"},{"key":"130_CR3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/ard.55.3.190","volume":"55","author":"AE Voskuyl","year":"1996","unstructured":"Voskuyl AE, Zwinderman AH, Westedt ML, et al.: Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis 1996, 55:190\u2013192.","journal-title":"Ann Rheum Dis"},{"key":"130_CR4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","volume":"62","author":"C Turesson","year":"2003","unstructured":"Turesson C, O\u2019Fallon WM, Crowson CS, et al.: Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46\u00a0years. Ann Rheum Dis 2003, 62:722\u2013727.","journal-title":"Ann Rheum Dis"},{"key":"130_CR5","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1002\/art.20588","volume":"50","author":"JD Gorman","year":"2004","unstructured":"Gorman JD, David-Vaudey E, Pai M, et al.: Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum 2004, 50:3476\u20133484.","journal-title":"Arthritis Rheum"},{"key":"130_CR6","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/art.22057","volume":"54","author":"C Turesson","year":"2006","unstructured":"Turesson C, Schaid DJ, Weyand CM, et al.: Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis. Arthritis Rheum 2006, 54:2776\u20132783.","journal-title":"Arthritis Rheum"},{"key":"130_CR7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/ard.2009.110411","volume":"69","author":"K Laskaria","year":"2010","unstructured":"Laskaria K, Ahmadi-Simab K, Lamken M, et al.: Are anti-cyclic citrullinated peptide autoantibodies seromarkers for rheumatoid vasculitis in a cohort of patients with systemic vasculitis? Ann Rheum Dis 2010, 69:469\u2013471.","journal-title":"Ann Rheum Dis"},{"key":"130_CR8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.57.2.114","volume":"57","author":"AE Voskuyl","year":"1998","unstructured":"Voskuyl AE, van Duinen SG, Zwinderman AH, et al.: The diagnostic value of perivascular infiltrates in muscle biopsy specimens for the assessment of rheumatoid vasculitis. Ann Rheum Dis 1998, 57:114\u2013117.","journal-title":"Ann Rheum Dis"},{"key":"130_CR9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03009740310004621","volume":"33","author":"C Turesson","year":"2004","unstructured":"Turesson C, Jacobsson LT: Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 2004, 33:65\u201372.","journal-title":"Scand J Rheumatol"},{"key":"130_CR10","first-page":"253","volume":"23","author":"O Kaye","year":"1996","unstructured":"Kaye O, Beckers CC, Paquet P, et al.: The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate. J Rheumatol 1996, 23:253\u2013257.","journal-title":"J Rheumatol"},{"key":"130_CR11","first-page":"242","volume":"19","author":"C Salvarani","year":"1992","unstructured":"Salvarani C, Macchioni P, Mantovani W, et al.: Extraarticular manifestations of rheumatoid arthritis and HLA antigens in northern Italy. J Rheumatol 1992, 19:242\u2013246.","journal-title":"J Rheumatol"},{"key":"130_CR12","first-page":"566","volume":"138","author":"MJ Wattiaux","year":"1987","unstructured":"Wattiaux MJ, Kahn MF, Thevenet JP, et al.: [Vascular involvement in rheumatoid polyarthritis. Retrospective study of 37 cases of rheumatoid polyarthritis with vascular involvement and review of the literature]. Ann Med Interne (Paris) 1987, 138:566\u2013587.","journal-title":"Ann Med Interne (Paris)"},{"key":"130_CR13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semarthrit.2006.04.006","volume":"36","author":"MS Genta","year":"2006","unstructured":"Genta MS, Genta RM, Gabay C: Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum 2006, 36:88\u201398.","journal-title":"Semin Arthritis Rheum"},{"key":"130_CR14","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.20158","volume":"50","author":"MM Ward","year":"2004","unstructured":"Ward MM: Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983\u20132001. Arthritis Rheum 2004, 50:1122\u20131131.","journal-title":"Arthritis Rheum"},{"key":"130_CR15","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/art.21047","volume":"52","author":"RA Watts","year":"2005","unstructured":"Watts RA, Lane SE, Scott DG: Decrease over time in the incidence of systemic rheumatoid vasculitis: comment on the article by Turesson et al. Arthritis Rheum 2005, 52:1620\u20131621; author reply 1621.","journal-title":"Arthritis Rheum"},{"key":"130_CR16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/keh210","volume":"43","author":"RA Watts","year":"2004","unstructured":"Watts RA, Mooney J, Lane SE, Scott DG: Rheumatoid vasculitis: becoming extinct? Rheumatology 2004, 43:920\u2013923.","journal-title":"Rheumatology"},{"key":"130_CR17","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1002\/art.20590","volume":"50","author":"C Turesson","year":"2004","unstructured":"Turesson C, McClelland RL, Christianson TJ, Matteson EL: No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study. Arthritis Rheum 2004, 50:3729\u20133731.","journal-title":"Arthritis Rheum"},{"key":"130_CR18","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/rheumatology\/38.7.668","volume":"38","author":"C Turesson","year":"1999","unstructured":"Turesson C, Jacobsson L, Bergstrom U: Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology 1999, 38:668\u2013674.","journal-title":"Rheumatology"},{"key":"130_CR19","first-page":"62","volume":"29","author":"C Turesson","year":"2002","unstructured":"Turesson C, O\u2019Fallon WM, Crowson CS, et al.: Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002, 29:62\u201367.","journal-title":"J Rheumatol"},{"key":"130_CR20","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/art.1780381114","volume":"38","author":"X Puechal","year":"1995","unstructured":"Puechal X, Said G, Hilliquin P, et al.: Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 1995, 38:1618\u20131629.","journal-title":"Arthritis Rheum"},{"key":"130_CR21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jbspin.2010.02.030","volume":"77","author":"N Caballol Pons","year":"2010","unstructured":"Caballol Pons N, Montala N, Valverde J, et al.: Isolated cerebral vasculitis associated with rheumatoid arthritis. Joint Bone Spine 2010, 77:361\u2013363.","journal-title":"Joint Bone Spine"},{"key":"130_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00296-007-0428-0","volume":"28","author":"M Zolcinski","year":"2008","unstructured":"Zolcinski M, Bazan-Socha S, Zwolinska G, Musial J: Central nervous system involvement as a major manifestation of rheumatoid arthritis. Rheumatol Int 2008, 28:281\u2013283.","journal-title":"Rheumatol Int"},{"key":"130_CR23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1365-2133.2002.04933.x","volume":"147","author":"KR Chen","year":"2002","unstructured":"Chen KR, Toyohara A, Suzuki A, Miyakawa S: Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis. Br J Dermatol 2002, 147:905\u2013913.","journal-title":"Br J Dermatol"},{"key":"130_CR24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/ard.62.5.407","volume":"62","author":"AE Voskuyl","year":"2003","unstructured":"Voskuyl AE, Hazes JM, Zwinderman AH, et al.: Diagnostic strategy for the assessment of rheumatoid vasculitis. Ann Rheum Dis 2003, 62:407\u2013413.","journal-title":"Ann Rheum Dis"},{"key":"130_CR25","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/art.1780351210","volume":"35","author":"IE Coremans","year":"1992","unstructured":"Coremans IE, Hagen EC, Daha MR, et al.: Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992, 35:1466\u20131475.","journal-title":"Arthritis Rheum"},{"key":"130_CR26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0002-9343(84)90654-5","volume":"76","author":"DG Scott","year":"1984","unstructured":"Scott DG, Bacon PA: Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med 1984, 76:377\u2013384.","journal-title":"Am J Med"},{"key":"130_CR27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0190-9622(86)70202-8","volume":"15","author":"LR Espinoza","year":"1986","unstructured":"Espinoza LR, Espinoza CG, Vasey FB, Germain BF: Oral methotrexate therapy for chronic rheumatoid arthritis ulcerations. J Am Acad Dermatol 1986, 15:508\u2013512.","journal-title":"J Am Acad Dermatol"},{"key":"130_CR28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0190-9622(87)70212-6","volume":"17","author":"KS Upchurch","year":"1987","unstructured":"Upchurch KS, Heller K, Bress NM: Low-dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis. J Am Acad Dermatol 1987, 17:355\u2013359.","journal-title":"J Am Acad Dermatol"},{"key":"130_CR29","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.1780310915","volume":"31","author":"R Segal","year":"1988","unstructured":"Segal R, Caspi D, Tishler M, et al.: Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Arthritis Rheum 1988, 31:1182\u20131185.","journal-title":"Arthritis Rheum"},{"key":"130_CR30","first-page":"153","volume":"2","author":"B Combe","year":"1993","unstructured":"Combe B, Didry C, Gutierrez M, et al.: Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis. Eur J Med 1993, 2:153\u2013156.","journal-title":"Eur J Med"},{"key":"130_CR31","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/archinte.1991.00400110099020","volume":"151","author":"AH Heurkens","year":"1991","unstructured":"Heurkens AH, Westedt ML, Breedveld FC: Prednisone plus azathioprine treatment in patients with rheumatoid arthritis complicated by vasculitis. Arch Intern Med 1991, 151:2249\u20132254.","journal-title":"Arch Intern Med"},{"key":"130_CR32","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.2007.081679","volume":"67","author":"X Puechal","year":"2008","unstructured":"\u2022\u2022 Puechal X, Miceli-Richard C, Mejjad O, et al.: Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Ann Rheum Dis 2008, 67:880\u2013884. This article reports on a series of cases of refractory systemic rheumatoid vasculitis treated with anti-TNF therapy that were ascertained via a European survey. Among nine cases, five complete remissions and one partial remission were reported. One patient failed and two stopped treatment.","journal-title":"Ann Rheum Dis"},{"key":"130_CR33","first-page":"759","volume":"32","author":"DJ Armstrong","year":"2005","unstructured":"Armstrong DJ, McCarron MT, Wright GD: Successful treatment of rheumatoid vasculitis-associated foot-drop with infliximab. J Rheumatol 2005, 32:759; author reply 759\u2013760.","journal-title":"J Rheumatol"},{"key":"130_CR34","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/41.10.1126","volume":"41","author":"P Bartolucci","year":"2002","unstructured":"Bartolucci P, Ramanoelina J, Cohen P, et al.: Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology (Oxford) 2002, 41:1126\u20131132.","journal-title":"Rheumatology (Oxford)"},{"key":"130_CR35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/rheumatology\/41.2.234","volume":"41","author":"C Garcia-Porrua","year":"2002","unstructured":"Garcia-Porrua C, Gonzalez-Gay MA: Successful treatment of refractory mononeuritis multiplex secondary to rheumatoid arthritis with the anti-tumour necrosis factor alpha monoclonal antibody infliximab. Rheumatology (Oxford) 2002, 41:234\u2013235.","journal-title":"Rheumatology (Oxford)"},{"key":"130_CR36","first-page":"433","volume":"33","author":"C Garcia-Porrua","year":"2006","unstructured":"Garcia-Porrua C, Gonzalez-Gay MA, Quevedo V: Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis? J Rheumatol 2006, 33:433; author reply 433\u2013434.","journal-title":"J Rheumatol"},{"key":"130_CR37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/ard.62.6.587","volume":"62","author":"L Unger","year":"2003","unstructured":"Unger L, Kayser M, Nusslein HG: Successful treatment of severe rheumatoid vasculitis by infliximab. Ann Rheum Dis 2003, 62:587\u2013588.","journal-title":"Ann Rheum Dis"},{"key":"130_CR38","first-page":"1607","volume":"32","author":"AE Bijl van der","year":"2005","unstructured":"van der Bijl AE, Allaart CF, Van Vugt J, et al.: Rheumatoid vasculitis treated with infliximab. J Rheumatol 2005, 32:1607\u20131609.","journal-title":"J Rheumatol"},{"key":"130_CR39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","volume":"86","author":"M Ramos-Casals","year":"2007","unstructured":"\u2022\u2022 Ramos-Casals M, Brito-Zeron P, Munoz S, et al.: Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 2007, 86:242\u2013251. This article describes a MEDLINE review of all published cases of autoimmune diseases attributed to anti-TNF agents through December 2006, including 113 reported vasculitis cases. The relative reported frequency with specific agents is discussed (etanercept, 59; infliximab, 47; adalimumab, 5; other, 2).","journal-title":"Medicine (Baltimore)"},{"issue":"3 Suppl 49","key":"130_CR40","first-page":"S23","volume":"26","author":"S Guignard","year":"2008","unstructured":"\u2022\u2022 Guignard S, Gossec L, Bandinelli F, Dougados M: Comparison of the clinical characteristics of vasculitis occurring during anti-tumor necrosis factor treatment or not in rheumatoid arthritis patients. A systematic review of 2707 patients, 18 vasculitis. Clin Exp Rheumatol 2008, 26(3 Suppl 49):S23\u2013S29. This large, single-center, retrospective analysis performed a case-cohort study to examine the causal relationship between TNF treatment and vasculitis to conclude that a minority of cases could potentially be attributed to anti-TNF drugs.","journal-title":"Clin Exp Rheumatol"},{"key":"130_CR41","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/rheumatology\/ken129","volume":"47","author":"M Hellmann","year":"2008","unstructured":"\u2022 Hellmann M, Jung N, Owczarczyk K, et al.: Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis. Rheumatology (Oxford) 2008, 47:929\u2013930. This brief report describes two cases of rheumatoid vasculitis ulcers successfully treated with rituximab following failure of standard DMARDs and prednisone.","journal-title":"Rheumatology (Oxford)"},{"key":"130_CR42","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/rheumatology\/kel318","volume":"45","author":"LV Maher","year":"2006","unstructured":"Maher LV, Wilson JG: Successful treatment of rheumatoid vasculitis-associated foot drop with rituximab. Rheumatology (Oxford) 2006, 45:1450\u20131451.","journal-title":"Rheumatology (Oxford)"},{"key":"130_CR43","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1346-8138.2009.00639.x","volume":"36","author":"MJ Kim","year":"2009","unstructured":"Kim MJ, Kim HO, Kim HY, Park YM: Rituximab-induced vasculitis: a case report and review of the medical published work. J Dermatol 2009, 36:284\u2013287.","journal-title":"J Dermatol"},{"key":"130_CR44","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/art.21650","volume":"54","author":"G Cambridge","year":"2006","unstructured":"Cambridge G, Stohl W, Leandro MJ, et al.: Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis Rheum 2006, 54:723\u2013732.","journal-title":"Arthritis Rheum"},{"key":"130_CR45","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/art.24637","volume":"60","author":"RB Jones","year":"2009","unstructured":"Jones RB, Ferraro AJ, Chaudhry AN, et al.: A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2009, 60:2156\u20132168.","journal-title":"Arthritis Rheum"},{"key":"130_CR46","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2796.2005.01494.x","volume":"257","author":"P Eriksson","year":"2005","unstructured":"Eriksson P: Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 2005, 257:540\u2013548.","journal-title":"J Intern Med"},{"key":"130_CR47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","volume":"173","author":"KA Keogh","year":"2006","unstructured":"Keogh KA, Ytterberg SR, Fervenza FC, et al.: Rituximab for refractory Wegener\u2019s granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 2006, 173:180\u2013187.","journal-title":"Am J Respir Crit Care Med"},{"key":"130_CR48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/sarh.2001.27719","volume":"31","author":"SA Albano","year":"2001","unstructured":"Albano SA, Santana-Sahagun E, Weisman MH: Cigarette smoking and rheumatoid arthritis. Semin Arthritis Rheum 2001, 31:146\u2013159.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-010-0130-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-010-0130-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-010-0130-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:49:53Z","timestamp":1559436593000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-010-0130-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,15]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["130"],"URL":"https:\/\/doi.org\/10.1007\/s11926-010-0130-1","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,15]]}}}